Predicting responses to omalizumab in antihistamine-refractory chronic urticaria: A real-world longitudinal study

Background: Treating chronic urticaria (CU) that is unresponsive to H1-antihistamines (H1AHs) is challenging, and the real-world effectiveness of omalizumab remains unclear. Objective: Our aim was to evaluate the real-world effectiveness of omalizumab, optimal response assessment timing, and predict...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hyun-Young Lee, PhD, Hyun-Seob Jeon, MD, Jae-Hyuk Jang, MD, Youngsoo Lee, MD, Yoo Seob Shin, MD, PhD, Dong-Ho Nahm, MD, PhD, Hae-Sim Park, MD, PhD, Young-Min Ye, MD, PhD
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2024-05-01
Edice:	Journal of Allergy and Clinical Immunology: Global
Témata:	Chronic urticaria omalizumab treatment response predictor total IgE
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2772829324000419
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!